Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Amy Schumer had a lot of success taking Ozempic for weight loss, quickly dropping 30 lbs. However, she still decided to quit ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to drugs like Ozempic, Wegovy and Mounjaro.

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

The Honourable Ya'ara Saks, Federal Minister of Mental Health and Addictions and Associate Minister of Health, and the Honourable Brian Comer, Nova Scotia's Minister of Addictions and Mental Health, ...

Cognizant announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata's life sciences ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The recent NICE approval of Mounjaro for adults with poorly controlled type 2 diabetes, particularly those unresponsive to treatments like metformin, presents additional challenges. Although it ...